Primary antibodies for immunohistochemistry CE/IVD - Dermatopathology

Primary antibodies for immunohistochemistry CE/IVD - Dermatopathology

Dermatopathology frequently requires immunohistochemical confirmation to accurately classify cutaneous neoplasms and selected inflammatory or lymphoproliferative disorders with overlapping morphological features. Primary antibodies for immunohistochemistry (IHC) CE/IVD use provide essential diagnostic support for the characterization of melanocytic, epithelial, adnexal, mesenchymal, vascular, histiocytic, hematolymphoid, and metastatic skin lesions.

The application of optimized immunohistochemical panels improves diagnostic accuracy, supports lineage determination, facilitates differential diagnosis, and may contribute to prognostic assessment and therapeutic stratification in selected clinical contexts, particularly in challenging skin biopsies and resection specimens. Immunohistochemistry has become an indispensable component of modern dermatopathology workflows, complementing conventional histomorphology and molecular diagnostic approaches.

Key Features of CE/IVD Dermatopathology Primary Antibodies

  • CE/IVD-compliant reagents intended for in vitro diagnostic applications in clinical pathology laboratories.
  • Validated performance on formalin-fixed, paraffin-embedded (FFPE) tissue specimens.
  • Designed to provide high analytical performance when used according to the manufacturer's validated protocols and instructions for use (IFUs).
  • Optimized staining protocols compatible with heat-induced epitope retrieval (HIER) methods.
  • Availability in ready-to-use and concentrated formats to support laboratory workflow flexibility.
  • Reproducible staining performance with optimized signal-to-background characteristics under validated assay conditions.
  • Compatibility with automated IHC staining platforms and standardized laboratory workflows, depending on assay validation and platform specifications.
  • Support for the interpretation of nuclear, cytoplasmic, membranous, and other diagnostically relevant subcellular staining patterns.
  • Lot-to-lot consistency supported by rigorous quality-control procedures and validation testing.
  • Comprehensive technical documentation, including instructions for use (IFUs), recommended controls, and interpretation guidance.